Literature DB >> 23250654

Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis.

Carlo Selmi1, Angela Ceribelli, John M Vierling.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23250654     DOI： 10.1007/s00281-012-0359-z

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN： 1863-2297            Impact factor:   9.623


× No keyword cloud information.
  42 in total

Review 1.  Occult hepatitis B virus infection.

Authors:  Giovanni Raimondo; Teresa Pollicino; Irene Cacciola; Giovanni Squadrito
Journal:  J Hepatol       Date:  2006-11-07       Impact factor: 25.083

2.  Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex.

Authors:  Tetsuro Shimakami; Daisuke Yamane; Rohit K Jangra; Brian J Kempf; Carolyn Spaniel; David J Barton; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-03       Impact factor: 11.205

3.  Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.

Authors:  Loïc Guillevin; Alfred Mahr; Patrice Callard; Pascal Godmer; Christian Pagnoux; Emmanuelle Leray; Pascal Cohen
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

4.  HBV-related HCC, clinical issues and therapy.

Authors:  Massimo Iavarone; Massimo Colombo
Journal:  Dig Liver Dis       Date:  2011-01       Impact factor: 4.088

5.  Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.

Authors:  Shiyan Yu; Jieliang Chen; Min Wu; Hui Chen; Nobuyuki Kato; Zhenghong Yuan
Journal:  J Gen Virol       Date:  2010-04-07       Impact factor: 3.891

6.  Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.

Authors:  Robert J Clifford; Jinghui Zhang; Daoud M Meerzaman; Myung-Soo Lyu; Ying Hu; Constance M Cultraro; Richard P Finney; Jenny M Kelley; Sol Efroni; Sharon I Greenblum; Cu V Nguyen; William L Rowe; Sweta Sharma; Gang Wu; Chunhua Yan; Hongen Zhang; Young-Hwa Chung; Jeong A Kim; Neung Hwa Park; Il Han Song; Kenneth H Buetow
Journal:  Hepatology       Date:  2010-12       Impact factor: 17.425

Review 7.  HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation.

Authors:  Anna Linda Zignego; Alessia Piluso; Carlo Giannini
Journal:  Autoimmun Rev       Date:  2008-12       Impact factor: 9.754

8.  Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

Authors:  Renate G van der Molen; Dave Sprengers; Rekha S Binda; Esther C de Jong; Hubert G M Niesters; Johannes G Kusters; Jaap Kwekkeboom; Harry L A Janssen
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

9.  Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

Authors:  Silvia Cermelli; Anna Ruggieri; Jorge A Marrero; George N Ioannou; Laura Beretta
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

10.  Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.

Authors:  M Lenzi; S Bellentani; G Saccoccio; P Muratori; F Masutti; L Muratori; F Cassani; F B Bianchi; C Tiribelli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.